Keywords
type 1 diabetes mellitus, stem cells, clinical trials.
How to Cite
Tronko, M., & Pasteur, I. (2013). Advances of regenerative medicine in the therapy of type 1 diabetes mellitus. III. Clinical trials in the use of stem cells for the therapy of main disease. Endokrynologia, 18(3), 53-63. Retrieved from https://endokrynologia.com.ua/index.php/journal/article/view/376
Abstract
Information are presented, on the clinical trials in the use of stem cells for the therapy of type 1 diabetes mellitus.
References
1. Burns C.J., Persaud S.J., Jones P.M. Stem cell therapy for diabetes: do we need to make beta cells? // J. Endocrinol. 2004, 183, 437-443.
2. Beckman J.A., Creager M.A., Libby P. Diabetes and atherosclerosis epidemiology, pathophysiology, and management // JAMA. 2002, 287, 2570-2581.
3. Secchiero P., Candido R., Corallini F. et al. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice // Circulation. 2006, 114, 1522-1530.
4. Noguchi H. Pancreatic stem/progenitor cells for the treatment of diabetes // Rev. Diabet. Stud. 2010, 7, 105-111.
5. Gregg E.W., Gu Q., Cheng Y.J. et al. Mortality trends in men and women with diabetes, 1971 to 2000 // Ann. Intern. Med. 2007, 147, 149-155.
6. Wild S., Roglic G., Green A. et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 // Diabetes Care. 2004, 27, 1047-1053.
7. Borowiak M. The new generation of beta-cells: replication, stem cell differentiation, and the role of small molecules // Rev. Diabet Stud. 2010, 7, 93-104.
8. Wagner R.T., Lewis J. et al. Stem cell approaches for the treatment of type 1 diabetes mellitus // Transpl. Res. 2010, 156, 169-179.
9. Довідник основних показників діяльності ендокринологічної служби України за 2012 рік // Ендокринологія. 2013, 18, № 1, додаток 1, 36 с.
10. Nathan D.M. Long-term complications of diabetes mellitus // N. Engl. J. Med. 1993, 328, 1676-1685.
11. The DCCT Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus // N. Engl. J. Med. 1993, 29, 977-986.
12. Аметов А.С. Перспективы развития диабетологии // Тер. архив. 2005, 10, 5-9.
13. Yechoor V., Chan L. Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation // Mol. Endocrinol. 2010, 24, 1501-1511.
14. Тронько Н.Д., Пастер И.П. Достижения регенеративной медицины в терапии сахарного диабета 1 типа. I. Источники получения b-клеток (1 частина) // Ендокринологія. 2012, 17, № 2, 66-73.
15. Тронько Н.Д., Пастер И.П. Достижения регенеративной медицины в терапии сахарного диабета 1 типа. I. Источники получения b-клеток (2 частина) // Ендокринологія. 2012, 17, № 3, 74-84.
2. Beckman J.A., Creager M.A., Libby P. Diabetes and atherosclerosis epidemiology, pathophysiology, and management // JAMA. 2002, 287, 2570-2581.
3. Secchiero P., Candido R., Corallini F. et al. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice // Circulation. 2006, 114, 1522-1530.
4. Noguchi H. Pancreatic stem/progenitor cells for the treatment of diabetes // Rev. Diabet. Stud. 2010, 7, 105-111.
5. Gregg E.W., Gu Q., Cheng Y.J. et al. Mortality trends in men and women with diabetes, 1971 to 2000 // Ann. Intern. Med. 2007, 147, 149-155.
6. Wild S., Roglic G., Green A. et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 // Diabetes Care. 2004, 27, 1047-1053.
7. Borowiak M. The new generation of beta-cells: replication, stem cell differentiation, and the role of small molecules // Rev. Diabet Stud. 2010, 7, 93-104.
8. Wagner R.T., Lewis J. et al. Stem cell approaches for the treatment of type 1 diabetes mellitus // Transpl. Res. 2010, 156, 169-179.
9. Довідник основних показників діяльності ендокринологічної служби України за 2012 рік // Ендокринологія. 2013, 18, № 1, додаток 1, 36 с.
10. Nathan D.M. Long-term complications of diabetes mellitus // N. Engl. J. Med. 1993, 328, 1676-1685.
11. The DCCT Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus // N. Engl. J. Med. 1993, 29, 977-986.
12. Аметов А.С. Перспективы развития диабетологии // Тер. архив. 2005, 10, 5-9.
13. Yechoor V., Chan L. Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation // Mol. Endocrinol. 2010, 24, 1501-1511.
14. Тронько Н.Д., Пастер И.П. Достижения регенеративной медицины в терапии сахарного диабета 1 типа. I. Источники получения b-клеток (1 частина) // Ендокринологія. 2012, 17, № 2, 66-73.
15. Тронько Н.Д., Пастер И.П. Достижения регенеративной медицины в терапии сахарного диабета 1 типа. I. Источники получения b-клеток (2 частина) // Ендокринологія. 2012, 17, № 3, 74-84.
Downloads
Download data is not yet available.